Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating markers of angiogenesis and endotheliopathy in COVID-19.
Pine AB, Meizlish ML, Goshua G, Chang CH, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan JM, Won CH, Price C, Dela Cruz CS, Halene S, van Dijk D, Hwa J, Lee AI, Chun HJ. Pine AB, et al. Among authors: meizlish ml. Pulm Circ. 2020 Nov 25;10(4):2045894020966547. doi: 10.1177/2045894020966547. eCollection 2020 Oct-Dec. Pulm Circ. 2020. PMID: 33282193 Free PMC article.
Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19.
Meizlish ML, Pine AB, Goshua G, Chang CH, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan J, Price C, Cruz CSD, Halene S, van Dijk D, Hwa J, Lee AI, Chun HJ. Meizlish ML, et al. medRxiv [Preprint]. 2020 Jul 1:2020.06.29.20140376. doi: 10.1101/2020.06.29.20140376. medRxiv. 2020. Update in: Pulm Circ. 2020 Nov 25;10(4):2045894020966547. doi: 10.1177/2045894020966547. PMID: 32637968 Free PMC article. Updated. Preprint.
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.
Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, DeFilippo N, Keating C, Liu Y, Mankbadi M, McManus D, Wang SY, Price C, Bona RD, Ochoa Chaar CI, Chun HJ, Pine AB, Rinder HM, Siner JM, Neuberg DS, Owusu KA, Lee AI. Meizlish ML, et al. Am J Hematol. 2021 Apr 1;96(4):471-479. doi: 10.1002/ajh.26102. Epub 2021 Feb 22. Am J Hematol. 2021. PMID: 33476420 Free PMC article. Clinical Trial.
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.
Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, DeFilippo N, Keating C, Liu Y, Mankbadi M, McManus D, Wang S, Price C, Bona RD, Chaar CIO, Chun HJ, Pine AB, Rinder HM, Siner J, Neuberg DS, Owusu KA, Lee AI. Meizlish ML, et al. medRxiv [Preprint]. 2021 Jan 15:2021.01.12.21249577. doi: 10.1101/2021.01.12.21249577. medRxiv. 2021. Update in: Am J Hematol. 2021 Apr 1;96(4):471-479. doi: 10.1002/ajh.26102. PMID: 33469595 Free PMC article. Updated. Preprint.
A neutrophil activation signature predicts critical illness and mortality in COVID-19.
Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun HJ. Meizlish ML, et al. Blood Adv. 2021 Mar 9;5(5):1164-1177. doi: 10.1182/bloodadvances.2020003568. Blood Adv. 2021. PMID: 33635335 Free PMC article.
A neutrophil activation signature predicts critical illness and mortality in COVID-19.
Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun H. Meizlish ML, et al. medRxiv [Preprint]. 2020 Sep 2:2020.09.01.20183897. doi: 10.1101/2020.09.01.20183897. medRxiv. 2020. Update in: Blood Adv. 2021 Mar 9;5(5):1164-1177. doi: 10.1182/bloodadvances.2020003568. PMID: 32908988 Free PMC article. Updated. Preprint.
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.
Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O'Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. Ma L, et al. bioRxiv [Preprint]. 2021 Feb 23:2021.02.22.432177. doi: 10.1101/2021.02.22.432177. bioRxiv. 2021. Update in: Sci Immunol. 2021 May 13;6(59):eabh2259. doi: 10.1126/sciimmunol.abh2259. PMID: 33655244 Free PMC article. Updated. Preprint.
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Goshua G, et al. Among authors: meizlish ml. Lancet Haematol. 2020 Aug;7(8):e575-e582. doi: 10.1016/S2352-3026(20)30216-7. Epub 2020 Jun 30. Lancet Haematol. 2020. PMID: 32619411 Free PMC article. Clinical Trial.
17 results